PML Monitoring and Educating Technicians

(7:15)

Monitoring a patient on natalizumab for JC virus

(1:55)

Dr Paul Molyneux - Managing PML risk in patients treated with Natalizumab.

(42:10)

What You Need to Know About Natalizumab (Tysabri®)

(9:21)

Risk Analysis of Natalizumab in Progressive Multifocal Leukoencephalopathy

(8:18)

Webinar: What is PML?

(35:5)

MRI imaging of a PML infection

(2:1econd)

Professor David Clifford - 'PML and multiple sclerosis'

(37:)

Highly Effective Disease-Modifying Therapies for Multiple Sclerosis

(31:37)

Update on PML

(28:35)

A PML risk genetic test to identify at-risk patients on natalizumab

(1:50)

MRI for monitoring response to MS disease-modifying therapies | MS Academy webinar

(48:29)

PML in the Biologic Era

(31:15)

Managing PML in the Multiple Sclerosis Patient

(30:9)

The Evaluation of PML Lesions Using MRI in Patients With Multiple Sclerosis

(5:3)

Risk of PML in Patients Taking Natalizumab

(2:3)

Risk Mitigation in Multiple Sclerosis Therapies

(34:)

'Top Gun' Conference - The Human Side of Condition Monitoring

(34:57)

Tysabri: PML Risk Thought Experiment

(6:16)

Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy - Risk and Risk Perception

(1:6:30)